Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Eaton

Showing results (301-310 of 318) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trialRenato G Martins, Upendra Parvathaneni, Julie E Bauman, et al.
Nature Communications|September 9, 2024
Merlin<sup>S13</sup> phosphorylation regulates meningioma Wnt signaling and magnetic resonance imaging featuresCharlotte D Eaton, Lauro Avalos, S John Liu, et al.
The Journal of Molecular Diagnostics : JMD|November 6, 2013
Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimensColin C Pritchard, Stephen J Salipante, Karen Koehler, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2015
A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancerG Giaccone, L A Bazhenova, J Nemunaitis, et al.
Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
Napsin A-specific T cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancerNatalie J Miller, Christina S Baik, Joel W Neal, et al.
Head & Neck|April 25, 2025
Dual PD-1 and CTLA4 Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Advanced Salivary Gland CancersCristina P Rodriguez, Qian Vicky Wu, Kevin Ng, et al.
BMJ Open|November 5, 2025
Three infections, one fight: an implementation study to map needle prevalence and evaluate HIV, syphilis and hepatitis C prevention interventions in Regina, Saskatchewan - a protocolAndrew D Eaton, Megan W Rowe, Shiny Mary Varghese, et al.
Journal for Immunotherapy of Cancer|July 15, 2025
Napsin A-specific T-cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancerNatalie J Miller, Christina Baik, Joel W Neal, et al.
Nature Genetics|May 17, 2024
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolutionCalixto-Hope G Lucas, Kanish Mirchia, Kyounghee Seo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2011
NCCN Clinical Practice Guidelines Occult primaryDavid S Ettinger, Mark Agulnik, Justin M M Cates, et al.
Pageof 32

Showing results (301-310 of 318) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trialRenato G Martins, Upendra Parvathaneni, Julie E Bauman, et al.
Nature Communications|September 9, 2024
Merlin<sup>S13</sup> phosphorylation regulates meningioma Wnt signaling and magnetic resonance imaging featuresCharlotte D Eaton, Lauro Avalos, S John Liu, et al.
The Journal of Molecular Diagnostics : JMD|November 6, 2013
Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimensColin C Pritchard, Stephen J Salipante, Karen Koehler, et al.
European Journal of Cancer (Oxford, England : 1990)|August 19, 2015
A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancerG Giaccone, L A Bazhenova, J Nemunaitis, et al.
Medrxiv : the Preprint Server for Health Sciences|March 31, 2025
Napsin A-specific T cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancerNatalie J Miller, Christina S Baik, Joel W Neal, et al.
Head & Neck|April 25, 2025
Dual PD-1 and CTLA4 Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Advanced Salivary Gland CancersCristina P Rodriguez, Qian Vicky Wu, Kevin Ng, et al.
BMJ Open|November 5, 2025
Three infections, one fight: an implementation study to map needle prevalence and evaluate HIV, syphilis and hepatitis C prevention interventions in Regina, Saskatchewan - a protocolAndrew D Eaton, Megan W Rowe, Shiny Mary Varghese, et al.
Journal for Immunotherapy of Cancer|July 15, 2025
Napsin A-specific T-cell clonotypes are associated with improved clinical outcomes in patients receiving checkpoint immunotherapy for metastatic non-small cell lung cancerNatalie J Miller, Christina Baik, Joel W Neal, et al.
Nature Genetics|May 17, 2024
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolutionCalixto-Hope G Lucas, Kanish Mirchia, Kyounghee Seo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2011
NCCN Clinical Practice Guidelines Occult primaryDavid S Ettinger, Mark Agulnik, Justin M M Cates, et al.
Pageof 32